The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning

Biagi, 2008, PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients, J. Pediatr. Hematol. Oncol., 30, 881, 10.1097/MPH.0b013e318180bc1d Bismuth, 1982, Prognosis and treatment of paraquat poisoning: a review of 28 cases, J. Toxicol. Clin. Toxicol., 19, 461, 10.3109/15563658208992501 Boehme, 2007, Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease, Nephrol. Dial. Transplant., 22, 2224, 10.1093/ndt/gfl747 Candan, 2001, Captopril inhibits the pulmonary toxicity of paraquat in rats, Hum. Exp. Toxicol., 20, 637, 10.1191/096032701718890540 Clark, 1966, The toxicity of paraquat, Br. J. Ind. Med., 23, 126 Dinis-Oliveira, 2008, Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment, Crit. Rev. Toxicol., 38, 13, 10.1080/10408440701669959 Eddleston, 2000, Patterns and problems of deliberate self-poisoning in the developing world, QJM, 93, 715, 10.1093/qjmed/93.11.715 Fukuda, 1985, Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis, Am. J. Pathol., 118, 452 Gando, 1999, Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis, J. Trauma, 47, 719, 10.1097/00005373-199910000-00017 Garlanda, 2005, Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility, Annu. Rev. Immunol., 23, 337, 10.1146/annurev.immunol.23.021704.115756 Gil, 2008, Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients, Clin. Toxicol., 46, 515, 10.1080/15563650701549403 Gil, 2007, Plasma surfactant D in patients following acute paraquat intoxication, Clin. Toxicol. (Phila.), 45, 463, 10.1080/15563650701338138 Han, 2011, Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury, Intens. Care Med., 37, 334, 10.1007/s00134-010-2067-2 Hart, 1987, Paraquat – a review of safety in agricultural and horticultural use, Hum. Toxicol., 6, 13, 10.1177/096032718700600103 Hart, 1984, A new statistical approach to the prognostic significance of plasma paraquat concentrations, Lancet, 2, 1222, 10.1016/S0140-6736(84)92784-3 He, 2010, PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation, Intens. Care Med., 36, 356, 10.1007/s00134-009-1720-0 He, 2007, Long pentraxin 3 in pulmonary infection and acute lung injury, Am. J. Physiol. Lung Cell. Mol. Physiol., 292, L1039, 10.1152/ajplung.00490.2006 Honore, 1994, Paraquat poisoning, “state of the art”, Acta Clin. Belg., 49, 220, 10.1080/17843286.1994.11718393 Huttunen, 2011, High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study, PLoS One, 6, e17653, 10.1371/journal.pone.0017653 Jylhava, 2011, Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey, Clin. Exp. Immunol., 164, 211, 10.1111/j.1365-2249.2011.04354.x Kaess, 2011, Heart failure: pentraxin 3-a marker of diastolic dysfunction and HF?, Nat. Rev. Cardiol., 8, 246, 10.1038/nrcardio.2011.50 Kao, 1999, Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome, Chest, 116, 709, 10.1378/chest.116.3.709 Kume, 2011, Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage, J. Cardiol., 58, 38, 10.1016/j.jjcc.2011.03.006 Latini, 2004, Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction, Circulation, 110, 2349, 10.1161/01.CIR.0000145167.30987.2E Li, 2010, Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis, Cochrane Database Syst. Rev., CD008084 Mauri, 2008, Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity, Crit. Care Med., 36, 2302, 10.1097/CCM.0b013e3181809aaf Muller, 2001, Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients, Crit. Care Med., 29, 1404, 10.1097/00003246-200107000-00017 Napoleone, 2002, Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation, Arterioscler. Thromb. Vasc. Biol., 22, 782, 10.1161/01.ATV.0000012282.39306.64 Napoleone, 2004, The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation, J. Leukoc. Biol., 76, 203, 10.1189/jlb.1003528 Okutani, 2007, High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats, Am. J. Physiol. Lung Cell. Mol. Physiol., 292, L144, 10.1152/ajplung.00002.2006 Savchenko, 2011, Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis, Pathol. Int., 61, 290, 10.1111/j.1440-1827.2011.02651.x Senarathna, 2009, Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration, QJM, 102, 251, 10.1093/qjmed/hcp006 Smith, 1976, Paraquat, CRC Crit. Rev. Toxicol., 4, 411, 10.1080/10408447609164020 Suliman, 2008, The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality, QJM, 101, 397, 10.1093/qjmed/hcn019 Suntres, 2002, Role of antioxidants in paraquat toxicity, Toxicology, 180, 65, 10.1016/S0300-483X(02)00382-7